The flagship product of HealthBeacon, which was founded a decade ago, is a smart sharps bin for use by patients who inject medication at home.
The company issued a warning in July last year, saying device sales targets were running behind schedule and that the 100,000 objective would not be met until March 2024 – as delays in securing computer chips temporarily held up production. The timeline was pushed out again earlier this year by a further three months.
While the company has been successful in striking distribution deals with US speciality pharma groups, it has been caught out by the red tape involved in rolling them out. Its current timelines are running up to nine months behind previous estimates.